Clincosm LogoSign in Get a demo

MDS

Showing NaN - NaN of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, Systemic Autoimmune Diseases Trial in France (Azacitidine)

Completed
  • MDS
  • Systemic Autoimmune Diseases
  • Amiens cedex 01, France
  • +58 more
Oct 3, 2022

MDS Trial in France (transplantation)

Active, not recruiting
  • MDS
  • transplantation
  • Amiens, France
  • +36 more
Jul 4, 2022

MDS, MDS Trial in France (Luspatercept Injection [Reblozyl], Eprex)

Recruiting
  • MDS
  • Myelodysplastic Syndromes
  • Luspatercept Injection [Reblozyl]
  • Eprex
  • Amiens, France
  • +30 more
May 19, 2022

MDS Trial in France (Decitabine, HYDROXYUREA)

Completed
  • MDS
  • Saint-Denis, La Réunion, France
  • +44 more
Nov 17, 2021

MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)

Completed
  • Myelodysplastic Syndromes
  • +3 more
  • ON 01910.Na
  • Scottsdale, Arizona
  • +86 more
Jun 29, 2020

MDS Trial in Bobigny (Azacitidine, Azacitidine associated with Valproic acid, Azacitidine associated with Lenalidomide)

Unknown status
  • MDS
  • Bobigny, France
    Avicenne hospital
Feb 18, 2019

MDS Trial in France (SGI-110 administration)

Completed
  • MDS
  • SGI-110 administration
  • Angers, France
  • +26 more
Dec 5, 2018

MDS Trial in France (Azacitidine and LDE255)

Completed
  • MDS
  • Azacitidine and LDE255
  • Amiens, France
  • +23 more
Dec 5, 2018

MDS Trial in Belgium, France (Deferasirox, Vitamin D and Azacitidine)

Unknown status
  • MDS
  • Deferasirox, Vitamin D and Azacitidine
  • Gent, Belgium
  • +14 more
Jan 9, 2018